What's to get? They release a paper and set a target that represents a very appealing rise in SP. They then get their clients onto it while dumping into the strength. Classic behavior.
Looking at the action today, it's clear that there is still a good deal of selling pressure and frankly, it's overwhelming the buyers. Buyers seem happy enough to park themselves at lower prices under the apparent knowledge that the selling hasn't yet stopped.
If more buyers don't step up to the plate (and I'm talking serious volume like we see on the other Co stocks), then we'll be fighting an uphill battle for a while yet.
More assays aren't expected for another fortnight and JORC will be pushed to March IMO. That leaves something unexpected like EM to come but without drilling the EM target it may prove to be another fizzle for the short term SP.
The TA points to it (IMO will retest the support line) and the news flow (that we know of) points to it: there's probably more weakness to come. Blessing in disguise as it's an opp to scoop up more shares closer to 11c but IMO we'll hold around 11c unless something genuinely exciting occurs.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)